Replies to post #332373 on Avid Bioservices Inc (CDMO)

[biopharm]

Nice to see Stephanie answers so quickly...but maybe Stephanie is not aware of all thing that some don't know .... we shall see...

______

Avid Bioservices expands facility, process development capabilities

April 25, 2018

...
...
Avid said it has four new clients interested in accelerating development of their biologic-based candidates. Though the company did not identify the clients, it said it is helping them develop drug candidates "for application in certain cell therapy, respiratory and oncology indications."

"In just a few months, we have already matched the total new client wins for all of calendar 2017, and we are continuing to work to convert a strong pipeline of additional opportunities," said Avid CEO Roger Lias in a statement.
...
...

https://www.biopharmadive.com/news/avid-bioservices-expands-facility-process-development-capabilities/522170/

[jakedogman1]

yes but the gene/vector biz is taking up capacity at other cdmo's which has an impact on the availability of capacity across the board.